Genome-Based Therapeutics: Targeted Drug Discovery and Development
Publisher: National Academies Press 2012
Number of pages: 89
Description:
Objectives: To examine the impact of and investment in genetic and genomic technologies and data in drug discovery and development; To examine and discuss the challenges for incorporating genomic technologies into drug development and to explore solutions to remedy those challenges; To discuss and explore how innovative, novel, and global partnerships between academia, industry, foundations, and government can enable the use of genomic information for more efficient and effective drug discovery and development programs.
Download or read it online for free here:
Download link
(940KB, PDF)
Similar books
Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciencesby Alfred N. Martin - Lea & Febiger
This book provides an introduction to the physiochemical and mathematical principles underlying the practice of pharmacy. The emphasis on new dosage forms and controlled delivery systems, problems and worked examples are some of the features.
(25633 views)
Essential Drugs: Practical Guidelinesby Jacques Pinel, et al. - Medecins sans Frontieres
The book provides simple, practical solutions to the questions and problems faced by medical staff, using the accumulated field experience, the recommendations of reference organizations and specialized documentation in each field.
(18641 views)
Neurotoxinsby J. Eric McDuffie (ed.) - InTech
Because the incidence of neurobehavioral hazards and risks of exogenous compounds remain subject matter of interest, predictive tools have evolved, including novel translational in vitro models, biomarkers, newer epidemiological research tools, etc.
(9729 views)
Improving and Accelerating Therapeutic Development for Nervous System Disorders- National Academies Press
The aim was to examine opportunities to accelerate drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling faster entry of potential treatments into first-in-human trials.
(10539 views)